Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited scores highest on Nitro (70) and lowest on Price (43). Its PosiPenta is 58.76 out of 100, around the middle of similar companies.
On the Penta Grid this week, Emcure Pharmaceuticals Limited is Grid #37 of 164 in the Healthcare sector in India, and Grid #454 of 2,328 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Emcure Pharmaceuticals Limited | 58.76 | 43 | 63 | 70 | 60 | 59 |
| Global Health Limited | 46.59 | 22 | 65 | 47 | 46 | 53 |
| Dr. Lal PathLabs Limited | 61.67 | 19 | 49 | 87 | 76 | 77 |
| Wockhardt Limited | 42.53 | 23 | 68 | 60 | 26 | 36 |
| Sai Life Sciences Limited | 46.85 | 14 | 50 | 74 | 59 | 37 |
| Krishna Institute of Medical Sciences Limited | 34.51 | 10 | 59 | 42 | 15 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 34.13 |
| P/B ratio | 6.98 |
EEarnings
| Trailing EPS | ₹53.35 |
| Forward EPS | ₹77.72 |
NNitro
| Price | 1820.60 |
| 52-week high | 2100.70 |
| 52-week low | 1306.50 |
| Fall from 52-week high | 13.3% |
TTorque
| Return on equity (ROE) (calculated) | 20.45% |
| Debt-to-equity | 0.31 |
AAnchor
| Beta (price swings) | -0.08 |
| Market cap | ₹34,538 Cr |
| Promoter holding | 77.83% |
| Dividend yield | 0.20% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Emcure Pharmaceuticals Limited's PosiPenta score?
Emcure Pharmaceuticals Limited's PosiPenta is 58.76 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Emcure Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, Emcure Pharmaceuticals Limited is Grid #37 of 164 in the Healthcare sector in India, and Grid #454 of 2,328 in India.
Which PosiPenta pillar is strongest for Emcure Pharmaceuticals Limited?
Nitro (momentum), with a score of 70 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Emcure Pharmaceuticals Limited?
Price (valuation), with a score of 43 out of 100: around the middle of similar companies.
Has Emcure Pharmaceuticals Limited's PosiPenta changed since last week?
Yes, it rose 0.90 points, from 57.86 to 58.76.
PositoAI is for research and education only and is not investment advice.